<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

MLYS

PremiumThe Fly

9h ago

RFK Jr. reconstituting vaccine advisory committee, retiring 17 current members

PremiumThe Fly

1d ago

RFK Jr. removes members of vaccine-advising CDC panel, CNBC reports

PremiumThe Fly

1d ago

AstraZeneca doses first patient in DESTINY-Endometrial01 trial

PremiumThe Fly

1d ago

PremiumThe FlyIonQ announces results from pact with AstraZeneca, Amazon.com and Nvidia

2d ago

AMZN

Study finds GLP-1s may have link to eye disease, STAT reports

The Fly

Study finds GLP-1s may have link to eye disease, STAT reports

4d ago

LLY

AstraZeneca’s Calquence approved in EU for treating CLL

The Fly

AstraZeneca’s Calquence approved in EU for treating CLL

5d ago

Vaccine opponent hired by RFK Jr. searches CDC record for autism link, WSJ says

PremiumThe Fly

5d ago

AstraZeneca’s Calquence Regimen Approved in EU for Untreated CLL

PremiumCompany Announcements

5d ago

PremiumRatings

AstraZeneca’s Promising Outlook: Buy Rating Backed by Positive DESTINY-Breast09 Trial Results and 35.5% Upside Potential

6d ago

Perrigo appoints Matt Winterman as Product Supply, Operation Strategy Officer

PremiumThe Fly

6d ago

GSK

PremiumThe FlyBristol deal takes out ‘key’ potential buyer of Summit Therapeutics, says Truist

8d ago

AstraZeneca Announces Share Capital and Voting Rights Update

Company Announcements

AstraZeneca Announces Share Capital and Voting Rights Update

8d ago

AstraZeneca says Enhertu combo showed PFS improvement over THP in trial

The Fly

AstraZeneca says Enhertu combo showed PFS improvement over THP in trial

8d ago

AstraZeneca, Daiichi Sankyo announce results from DESTINY-Breast09 Phase III

PremiumThe Fly

8d ago

Guardant Health announces results of Phase III SERENA-6 trial

PremiumThe Fly

9d ago

AstraZeneca’s Promising Clinical Data and Strategic Trials Justify Buy Rating

PremiumRatings

9d ago

AstraZeneca, Daiichi announce results from three trials on DATROWAY

PremiumThe Fly

9d ago

PremiumThe FlyAstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

9d ago

AstraZeneca announces results from SERENA-6 Phase III trial

The Fly

AstraZeneca announces results from SERENA-6 Phase III trial

9d ago

AstraZeneca, Daiichi announces results from DESTINY-Gastric04 phase 3 trial

The Fly

AstraZeneca, Daiichi announces results from DESTINY-Gastric04 phase 3 trial

9d ago